Hedge fund Dana Investment Advisors reduced stake in Cytokinetics, while Seven Eight Capital bought shares in CymaBay and Arrowhead Pharmaceuticals.

hedge fund Dana Investment Advisors reduced its Cytokinetics stake by 9.0% in Q3, while other institutional investors increased theirs. CymaBay Therapeutics saw Seven Eight Capital LP buy 41,556 shares in Q3, and the company reported a ($0.35) EPS for the quarter, missing estimates by ($0.04). Arrowhead Pharmaceuticals saw a 317% increase in Seven Eight Capital's holdings and has received positive ratings from some analysts.